Intracellular RNA Sensing in Mammalian Cells: Role in Stress Response and Cancer Therapies.

Int Rev Cell Mol Biol

Department of Radiation and Cellular Oncology and Ludwig Center for Metastasis Research, The University of Chicago, Chicago, IL, United States. Electronic address:

Published: January 2020

DNA damage has been considered the primary action of ionizing radiation (IR) in normal and tumor cells resulting in cell autonomous death. However, recent findings have elucidated novel local and systemic effects of IR mediated by the induction of Type I interferons (IFN) and activation of adaptive immune responses. These responses are initiated by DNA- and RNA-dependent activation of pattern recognition receptors (PRR) which comprise an innate immunity system responsible for detection of exogenous pathogens, mounting of an anti-viral response, and activation of adaptive immunity. Activation of cytoplasmic RNA sensors by endogenous dsRNAs has emerged as an important mechanism of tumor cell-intrinsic Type I IFN induction in the response to genotoxic therapies. The fact that an effective anti-tumor effect of IR and chemotherapy response is dependent on the RNA sensing pathways indicates that tumor cells are equipped by functional innate immunity system which recognizes genotoxic stress insult as an intrusion of exogenous RNA pathogens. This indicates that DNA damage leads to the RNA stress, which is recognized as danger-associated molecular patterns (DAMPs) presented by aberrant RNA molecules interacting with cytoplasmic RNA sensors. In the current review, we will discuss the mechanistic bases for RNA-dependent innate responses in tumor cells, RNA ligands recognized as DAMPs, and the potential implications of these findings to improve cancer therapies.

Download full-text PDF

Source
http://dx.doi.org/10.1016/bs.ircmb.2018.08.005DOI Listing

Publication Analysis

Top Keywords

tumor cells
12
rna sensing
8
cancer therapies
8
dna damage
8
activation adaptive
8
innate immunity
8
immunity system
8
cytoplasmic rna
8
rna sensors
8
rna
7

Similar Publications

[Next-generation sequencing-based minimal residual disease detection reveals clonal evolution in pediatric acute B-lymphoblastic leukemia: a case report and literature review].

Zhonghua Xue Ye Xue Za Zhi

December 2024

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China Tianjin Institutes of Health Science, Tianjin 301600, China.

Minimal residual disease (MRD), a crucial biomarker for assessing efficacy and predicting recurrence, refers to residual tumor cells remaining in the body of patients with hematological malignancies who achieved complete remission after treatment. This study aimed to conduct a retrospective analysis of the clinical diagnosis, treatment, and MRD monitoring of a pediatric patient with multiple acute B-lymphocytic leukemia relapses, alongside a review of relevant literature. In this case, Ig rearrangement based on next-generation sequencing (NGS) was more accurate in assessing the MRD level, compared with the traditional method of MRD detection, indicating the risk of earlier relapse and guided interventions in time.

View Article and Find Full Text PDF

The application of standardized criteria to evaluate treatment efficacy is crucial for guiding therapeutic decisions, assessing prognosis, and interpreting outcomes in treating multiple myeloma (MM). The unique characteristics of MM make its response assessment more complex compared with other malignancies. It primarily depends on serum and urine M protein levels, combined with the number of plasma cells in the bone marrow and comprehensive imaging findings.

View Article and Find Full Text PDF

Identification of lactylation-associated fibroblast subclusters predicting prognosis and cancer immunotherapy response in colon cancer.

Gene

January 2025

Department of Gastroenterology, The Third Xiangya Hospital, Central South University, Changsha, China; Hunan Key Laboratory of Non-resolving Inflammation and Cancer, Changsha, China. Electronic address:

Background: Lactylation plays an important role in tumor progression. This study aimed to clarify the impact of lactylation on cancer-associated fibroblasts(CAFs).

Methods: Single-cell and bulk RNA sequence data, along with survival information, were obtained from TCGA and GEO datasets.

View Article and Find Full Text PDF

Linking tumor immune infiltration to enhanced longevity in recurrence-free breast cancer.

ESMO Open

January 2025

Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Institute of Cancer and Blood Diseases, Hospital Clinic of Barcelona, Barcelona, Spain; Reveal Genomics, Barcelona, Spain. Electronic address:

Background: The infiltration of tumor-infiltrating B cells and plasma cells in early-stage breast cancer has been associated with a reduced risk of distant metastasis. However, the influence of B-cell tumor infiltration on overall patient survival remains unclear.

Materials And Methods: This study explored the relationship between an antitumor immune response, measured by a 14-gene B-cell/immunoglobulin (IGG) signature, and mortality risk in 9638 breast cancer patients across three datasets.

View Article and Find Full Text PDF

Magnetic nanoparticles (MNPs) used for magnetic hyperthermia can not only damage tumor cells after elevating to a specific temperature but also provide the temperature required for thermosensitive liposomes (TSL) to release doxorubicin (DOX). MNPs injected into tumor will generate heat under an alternating magnetic field, so the MNPs distribution can determine temperature distribution and further affect the DOX concentration used for tumor therapy. This study proposes an asynchronous injection strategy for this combination therapy in order to improve the DOX concentration value for drug therapy, in which the MNPs are injected into tumor after a certain lagging of TSL injection in order to increase the TSL concentration inside tumor.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!